Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage-Reference-Cited by-同舟云学术

Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage

Published:2022-11-04 Issue: Volume: Page:
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Ke Zhi-Bin,Chen Jia-Yin,You Qi,Sun Jiang-Bo,Xue Yu-Ting,Ye Xiao-Jian,Chen Shao-Hao,Xue Xue-Yi,Sun Xiong-Lin,Chen Dong-Ning,Wei Yong,Zheng Qing-Shui,Chen Shao-Ming,Xu Ning

Funder

Startup Fund for Scientific Research of Fujian Medical University

Fujian Provincial Health Technology Project

the “Eyas Plan” Youth Top-notch Talent Project of Fujian Province

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04438-8.pdf

Reference38 articles.

1. Afshar-Oromieh A, Babich JW, Kratochwil C, Giesel FL, Eisenhut M, Kopka K et al (2016) The rise of PSMA ligands for diagnosis and therapy of prostate cancer. J Nucl Med 57(Suppl 3):79s–89s

2. Attard G, Antonarakis ES (2016) Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide. Nat Rev Urol 13(12):697–698

3. Awenat S, Piccardo A, Carvoeiras P, Signore G, Giovanella L, Prior JO et al (2021) Diagnostic role of (18)F-PSMA-1007 PET/CT in prostate cancer staging: a systematic review. Diagnostics (basel). 11(3):552

4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

5. Emmett L, Yin C, Crumbaker M, Hruby G, Kneebone A, Epstein R et al (2019) Rapid modulation of PSMA expression by androgen deprivation: serial (68)Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade. J Nucl Med 60(7):950–954

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Clinic Machine Learning Classifier for the Prediction of Risk Stratifications of Prostate Cancer Bone Metastasis Progression to Castration Resistance;International Journal of General Medicine;2024-06